March 25, 2019 10:30 AM EDTUpdated 11:05 AM

J&J, Bayer agree to $775M payout to settle Xarelto litigation; Biogen launches $5B buyback in the wake of a disaster; Hookipa pitches $86M IPO

→ Right on deadline this morning we learned that J&J and Bayer have reached a deal to settle their outstanding litigation on Xarelto with a …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

J&J, Bay­er agree to $775M pay­out to set­tle Xarel­to lit­i­ga­tion; Bio­gen launch­es $5B buy­back in the wake of a dis­as­ter; Hookipa pitch­es $86M IPO